Mechanisms of weight loss and improved metabolism following bariatric surgery

Annals of the New York Academy of Sciences

Volumn 1411, Issue 1, 2018, Pages 53-64

  Mulla, Christopher M ^a,b   Middelbeek, Roeland J W ^a,b   Patti, Mary Elizabeth ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adjustable gastric band; bariatric surgery; obesity; Roux en Y gastric bypass; sleeve gastrectomy

Indexed keywords

BILE ACID; CARBOHYDRATE; FAT; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY; PROTEIN; TRACE ELEMENT;

ABSORPTION; APPETITE; BARIATRIC SURGERY; BODY WEIGHT LOSS; CALORIE; CARBOHYDRATE INTAKE; CENTRAL NERVOUS SYSTEM; COMPARATIVE EFFECTIVENESS; ENERGY BALANCE; FOOD INTAKE; FOOD PREFERENCE; GASTROINTESTINAL TRACT; HORMONE RELEASE; HUMAN; HYPOTHALAMUS; INTESTINE; INTESTINE ADAPTATION; INTESTINE FLORA; MACRONUTRIENT; METABOLISM; MICROBIOME; NONHUMAN; OBESITY; ODOR; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; PLASTICITY; POSTOPERATIVE PERIOD; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SURGICAL PATIENT; TASTE; WEIGHT; CALORIC INTAKE; CLINICAL TRIAL (TOPIC); ENERGY METABOLISM; FEEDING BEHAVIOR; PATHOPHYSIOLOGY; PHARMACOKINETICS; PREVALENCE; PROCEDURES; REWARD; VAGUS NERVE;

APPETITE; BARIATRIC SURGERY; BILE ACIDS AND SALTS; CLINICAL TRIALS AS TOPIC; ENERGY INTAKE; ENERGY METABOLISM; FEEDING BEHAVIOR; GASTROINTESTINAL HORMONES; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; NUTRIENTS; OBESITY; PREVALENCE; REWARD; VAGUS NERVE; WEIGHT LOSS;

EID: 85044524122     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.13409     Document Type: Review

References (149)

1. Ng, M. et al. 2014. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384: 766–781.
2. Flegal, K.M. et al. 2016. Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315: 2284–2291.
3. Manson, J.E. et al. 1995. Body weight and mortality among women. N. Engl. J. Med. 333: 677–685.
4. Calle, E.E. et al. 1999. Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 341: 1097–1105.
5. Garrison, R.J. & W.P. Castelli. 1985. Weight and thirty-year mortality of men in the Framingham Study. Ann. Intern. Med. 103(Pt 2): 1006–1009.
6. Semlitsch, T. et al. 2016. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database Syst. Rev. 3: CD008274.
7. Poirier, P. et al. 2006. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler. Thromb. Vasc. Biol. 26: 968–976.
8. Kales, A. et al. 1985. Severe obstructive sleep apnea–I: onset, clinical course, and characteristics. J. Chronic Dis. 38: 419–425.
9. Davis, M.A. et al. 1988. Sex differences in osteoarthritis of the knee. The role of obesity. Am. J. Epidemiol. 127: 1019–1030.
10. Hartz, A.J. et al. 1986. The association of obesity with joint pain and osteoarthritis in the HANES data. J. Chronic Dis. 39: 311–319.
11. Lauby-Secretan, B. et al. 2016. Body fatness and cancer—viewpoint of the IARC Working Group. N. Engl. J. Med. 375: 794–798.
12. Cawley, J. & C. Meyerhoefer. 2012. The medical care costs of obesity: an instrumental variables approach. J. Health Econ. 31: 219–230.
13. Finkelstein, E.A. et al. 2009. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff. (Millwood) 28: w822–w831.
14. Ponce, J. et al. 2015. American society for metabolic and bariatric surgery estimation of bariatric surgery procedures in the United States, 2011–2014. Surg. Obes. Relat. Dis. 11: 1199–1200.
15. Ponce, J. et al. 2016. American society for metabolic and bariatric surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg. Obes. Relat. Dis. 12: 1637–1639.
16. Henrikson, V. 1994. Can Small bowel resection be defended as therapy for obesity? Obes. Surg. 4: 54.
17. Angrisani, L. et al. 2015. Bariatric surgery worldwide 2013. Obes. Surg. 25: 1822–1832.
18. Schauer, P.R. et al. 2003. Laparoscopic gastric bypass surgery: current technique. J. Laparoendosc. Adv. Surg. Tech. A 13: 229–239.
19. Khan, S. et al. 2016. Trends in bariatric surgery from 2008 to 2012. Am. J. Surg. 211: 1041–1046.
20. Schauer, P.R. et al. 2017. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N. Engl. J. Med. 376: 641–651.
21. Halperin, F. et al. 2014. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 149: 716–726.
22. Courcoulas, A.P. et al. 2014. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 149: 707–715.
23. Mingrone, G. et al. 2015. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386: 964–973.
24. Courcoulas, A.P. et al. 2015. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 150: 931–940.
25. Cummings, D.E. et al. 2016. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia 59: 945–953.
26. Panosian, J. et al. 2017. Physical activity in obese type 2 diabetes after gastric bypass or medical management. Am. J. Med. 130: 83–92.
27. Coleman, K.J. et al. 2014. Three-year weight outcomes from a bariatric surgery registry in a large integrated healthcare system. Surg. Obes. Relat. Dis. 10: 396–403.
28. O'Brien, P.E. 2010. Bariatric surgery: mechanisms, indications and outcomes. J. Gastroenterol. Hepatol. 25: 1358–1365.
29. Carswell, K.A. et al. 2014. The effect of bariatric surgery on intestinal absorption and transit time. Obes. Surg. 24: 796–805.
30. Dirksen, C. et al. 2013. Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass. Neurogastroenterol. Motil. 25: 346–e255.
31. Kumar, R. et al. 2011. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery 149: 654–661.
32. Odstrcil, E.A. et al. 2010. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am. J. Clin. Nutr. 92: 704–713.
33. Fedorak, R.N. et al. 1987. Intestinal adaptation to diabetes. Altered Na-dependent nutrient absorption in streptozocin-treated chronically diabetic rats. J. Clin. Invest. 79: 1571–1578.
34. Ferraris, R.P. & H.V. Carey. 2000. Intestinal transport during fasting and malnutrition. Annu. Rev. Nutr. 20: 195–219.
35. Seeley, R.J., A.P. Chambers & D.A. Sandoval. 2015. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab. 21: 369–378.
36. Iqbal, C.W. et al. 2008. Mechanisms of ileal adaptation for glucose absorption after proximal-based small bowel resection. J. Gastrointest. Surg. 12: 1854–1864; discussion 1864–1865.
37. Saeidi, N. et al. 2013. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 341: 406–410.
38. Makinen, J. et al. 2015. Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery. Diabetologia 58: 1055–1062.
39. Cavin, J.B. et al. 2016. Differences in alimentary glucose absorption and intestinal disposal of blood glucose after Roux-en-Y gastric bypass vs sleeve gastrectomy. Gastroenterology 150: 454–464. e9.
40. Baud, G. et al. 2016. Bile diversion in Roux-en-Y gastric bypass modulates sodium-dependent glucose intestinal uptake. Cell Metab. 23: 547–553.
41. Halverson, J.D. 1986. Micronutrient deficiencies after gastric bypass for morbid obesity. Am. Surg. 52: 594–598.
42. Avinoah, E., A. Ovnat & I. Charuzi. 1992. Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery 111: 137–142.
43. Rhode, B.M. et al. 1996. Vitamin B-12 deficiency after gastric surgery for obesity. Am. J. Clin. Nutr. 63: 103–109.
44. Shankar, P., M. Boylan & K. Sriram. 2010. Micronutrient deficiencies after bariatric surgery. Nutrition 26: 1031–1037.
45. Suhl, E. et al. 2017. Medical nutrition therapy for post-bariatric hypoglycemia: practical insights. Surg. Obes. Relat. Dis. 13: 888–896.
46. Brolin, R.E. et al. 1994. Weight loss and dietary intake after vertical banded gastroplasty and Roux-en-Y gastric bypass. Ann. Surg. 220: 782–790.
47. Bobbioni-Harsch, E. et al. 2002. Factors influencing energy intake and body weight loss after gastric bypass. Eur. J. Clin. Nutr. 56: 551–556.
48. Coughlin, K. 1983. Preoperative and postoperative assessment of nutrient intakes in patients who have undergone gastric bypass surgery. Arch. Surg. 118: 813.
49. Molin Netto, B.D. et al. 2017. Eating patterns and food choice as determinant of weight loss and improvement of metabolic profile after RYGB. Nutrition 33: 125–131.
50. Miller, G.D., A. Norris & A. Fernandez. 2014. Changes in nutrients and food groups intake following laparoscopic Roux-en-Y gastric bypass (RYGB). Obes. Surg. 24: 1926–1932.
51. Warde-Kamar, J. et al. 2004. Calorie intake and meal patterns up to 4 years after Roux-en-Y gastric bypass surgery. Obes. Surg. 14: 1070–1079.
52. Kenler, H.A., R.E. Brolin & R.P. Cody. 1990. Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass. Am. J. Clin. Nutr. 52: 87–92.
53. Thomas, J.R. & E. Marcus. 2008. High and low fat food selection with reported frequency intolerance following Roux-en-Y gastric bypass. Obes. Surg. 18: 282–287.
54. Behary, P. & A.D. Miras. 2015. Food preferences and underlying mechanisms after bariatric surgery. Proc. Nutr. Soc. 74: 419–425.
55. Olbers, T. et al. 2006. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann. Surg. 244: 715–722.
56. Scholtz, S. et al. 2014. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut 63: 891–902.
57. Ochner, C.N. et al. 2012. Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery. Neuroscience 209: 128–135.
58. Ochner, C.N. et al. 2011. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann. Surg. 253: 502–507.
59. le Roux, C.W. et al. 2011. Gastric bypass reduces fat intake and preference. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301: R1057–R1066.
60. Cummings, D.E. 2015. Taste and the regulation of food intake: it's not just about flavor. Am. J. Clin. Nutr. 102: 717–718.
61. Makaronidis, J.M. et al. 2016. Reported appetite, taste and smell changes following Roux-en-Y gastric bypass and sleeve gastrectomy: effect of gender, type 2 diabetes and relationship to post-operative weight loss. Appetite 107: 93–105.
62. El Labban, S., B. Safadi & A. Olabi. 2016. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on taste acuity and sweetness acceptability in postsurgical subjects. Nutrition 32: 1299–1302.
63. Scruggs, D.M., C. Buffington & G.S. Cowan, Jr. 1994. Taste acuity of the morbidly obese before and after gastric bypass surgery. Obes. Surg. 4: 24–28.
64. Henkin, R.I. et al. 1972. Abnormalities of taste and smell in Sjogren's syndrome. Ann. Intern. Med. 76: 375–383.
65. Greger, J.L. & A.H. Geissler. 1978. Effect of zinc supplementation on taste acuity of the aged. Am. J. Clin. Nutr. 31: 633–637.
66. Calvo, S.S. & J.M. Egan. 2015. The endocrinology of taste receptors. Nat. Rev. Endocrinol. 11: 213–227.
67. Mathes, C.M. et al. 2012. Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302: R751–R767.
68. Miras, A.D. & C.W. le Roux. 2010. Bariatric surgery and taste: novel mechanisms of weight loss. Curr. Opin. Gastroenterol. 26: 140–145.
69. Halmi, K.A. et al. 1981. Appetitive behavior after gastric bypass for obesity. Int. J. Obes. 5: 457–464.
70. Bray, G.A. et al. 1980. Factors controlling food intake: a comparison of dieting and intestinal bypass. Am. J. Clin. Nutr. 33(2 Suppl.): 376–382.
71. Mathes, C.M. & A.C. Spector. 2012. Food selection and taste changes in humans after Roux-en-Y gastric bypass surgery: a direct-measures approach. Physiol. Behav. 107: 476–483.
72. Laurenius, A. et al. 2012. Changes in eating behaviour and meal pattern following Roux-en-Y gastric bypass. Int. J. Obes. (Lond.) 36: 348–355.
73. Miras, A.D. et al. 2012. Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am. J. Clin. Nutr. 96: 467–473.
74. Morton, G.J. et al. 2006. Central nervous system control of food intake and body weight. Nature 443: 289–295.
75. Stefater, M.A. et al. 2010. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 138: 2426–2436. e1–3.
76. Hatoum, I.J. et al. 2012. Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J. Clin. Endocrinol. Metab. 97: E1023–E1031.
77. Berthoud, H.R. 2008. Vagal and hormonal gut–brain communication: from satiation to satisfaction. Neurogastroenterol. Motil. 20(Suppl. 1): 64–72.
78. Gribble, F.M. 2012. The gut endocrine system as a coordinator of postprandial nutrient homoeostasis. Proc. Nutr. Soc. 71: 456–462.
79. Schwartz, M.W. et al. 2000. Central nervous system control of food intake. Nature 404: 661–671.
80. Berthoud, H.R., A.C. Shin & H. Zheng. 2011. Obesity surgery and gut–brain communication. Physiol. Behav. 105: 106–119.
81. le Roux, C.W. et al. 2005. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J. Clin. Endocrinol. Metab. 90: 4521–4524.
82. Hao, Z. et al. 2014. Vagal innervation of intestine contributes to weight loss After Roux-en-Y gastric bypass surgery in rats. Obes. Surg. 24: 2145–2151.
83. Ballsmider, L.A. et al. 2015. Sleeve gastrectomy and Roux-en-Y gastric bypass alter the gut–brain communication. Neural. Plast. 2015: 601985.
84. Campbell, J.E. & D.J. Drucker. 2013. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 17: 819–837.
85. Meek, C.L. et al. 2016. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides 77: 28–37.
86. Batterham, R.L. et al. 2002. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650–654.
87. Batterham, R.L. et al. 2007. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450: 106–109.
88. Reinehr, T. et al. 2007. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes. Surg. 17: 1571–1577.
89. Korner, J. et al. 2009. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int. J. Obes. (Lond.) 33: 786–795.
90. Nannipieri, M. et al. 2013. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J. Clin. Endocrinol. Metab. 98: 4391–4399.
91. Chandarana, K. et al. 2011. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes 60: 810–818.
92. le Roux, C.W. et al. 2006. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann. Surg. 243: 108–114.
93. le Roux, C.W. et al. 2007. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann. Surg. 246: 780–785.
94. Dar, M.S. et al. 2012. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)? Obes. Surg. 22: 1077–1083.
95. Yousseif, A. et al. 2014. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes. Surg. 24: 241–252.
96. Shak, J.R. et al. 2008. The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes. Surg. 18: 1089–1096.
97. Ye, J. et al. 2014. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am. J. Physiol. Regul. Integr. Comp. Physiol. 306: R352–R362.
98. De Silva, A. et al. 2011. The gut hormones PYY 3–36 and GLP-1 7–36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab. 14: 700–706.
99. Rao, R.S. & S. Kini. 2011. GIP and bariatric surgery. Obes. Surg. 21: 244–252.
100. Meier, J.J. et al. 2002. Gastric inhibitory polypeptide: the neglected incretin revisited. Regul. Pept. 107: 1–13.
101. Rubino, F. et al. 2004. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann. Surg. 240: 236–242.
102. Clements, R.H. et al. 2004. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am. Surg. 70: 1–4; discussion 4–5.
103. DePaula, A.L. et al. 2009. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20–34. Surg. Endosc. 23: 1724–1732.
104. Korner, J. et al. 2007. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg. Obes. Relat. Dis. 3: 597–601.
105. Farey, J.E. et al. 2017. Effect of laparoscopic sleeve gastrectomy on fasting gastrointestinal, pancreatic, and adipose-derived hormones and on non-esterified fatty acids. Obes. Surg. 27: 399–407.
106. Berthoud, H.R. 2011. Metabolic and hedonic drives in the neural control of appetite: who is the boss? Curr. Opin. Neurobiol. 21: 888–896.
107. Cummings, D.E. et al. 2002. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346: 1623–1630.
108. Holdstock, C. et al. 2003. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J. Clin. Endocrinol. Metab. 88: 3177–3183.
109. Faraj, M. et al. 2003. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J. Clin. Endocrinol. Metab. 88: 1594–1602.
110. Stoeckli, R. et al. 2004. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes. Res. 12: 346–350.
111. Gelisgen, R. et al. 2012. Effects of laparoscopic gastric band applications on plasma and fundic acylated ghrelin levels in morbidly obese patients. Obes. Surg. 22: 299–305.
112. Scott, W.R. & R.L. Batterham. 2011. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301: R15–R27.
113. Schjoldager, B.T. et al. 1988. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur. J. Clin. Invest. 18: 499–503.
114. Turnbaugh, P.J. et al. 2007. The human microbiome project. Nature 449: 804–810.
115. Martinez, K.B., J.F. Pierre & E.B. Chang. 2016. The gut microbiota: the gateway to improved metabolism. Gastroenterol. Clin. North Am. 45: 601–614.
116. David, L.A. et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559–563.
117. Sonnenburg, E.D. et al. 2016. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529: 212–215.
118. Turnbaugh, P.J. et al. 2009. A core gut microbiome in obese and lean twins. Nature 457: 480–484.
119. Greenblum, S., P.J. Turnbaugh & E. Borenstein. 2012. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc. Natl. Acad. Sci. U.S.A. 109: 594–599.
120. Turnbaugh, P.J. et al. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027–1031.
121. Gill, S.R. et al. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355–1359.
122. Everard, A. et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 110: 9066–9071.
123. Turnbaugh, P.J. et al. 2009. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 1: 6ra14.
124. Vrieze, A. et al. 2012. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143: 913–916. e7.
125. Yan, M. et al. 2016. Effect of Roux-en-Y gastric bypass surgery on intestinal Akkermansia muciniphila. World J. Gastrointest. Surg. 8: 301–307.
126. Backhed, F. et al. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101: 15718–15723.
127. Sonnenburg, J.L. et al. 2005. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307: 1955–1959.
128. Topping, D.L. & P.M. Clifton. 2001. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81: 1031–1064.
129. Liou, A.P. et al. 2013. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci. Transl. Med. 5: 178ra41.
130. Li, J.V. et al. 2011. Metabolic surgery profoundly influences gut microbial–host metabolic cross-talk. Gut 60: 1214–1223.
131. Furet, J.P. et al. 2010. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59: 3049–3057.
132. Zhang, H. et al. 2009. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. U.S.A. 106: 2365–2370.
133. Dethlefsen, L. & D.A. Relman. 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1): 4554–4561.
134. Watanabe, M. et al. 2006. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439: 484–489.
135. Suzuki, T. et al. 2014. Correlation between postprandial bile acids and body fat mass in healthy normal-weight subjects. Clin. Biochem. 47: 1128–1131.
136. Brighton, C.A. et al. 2015. Bile acids trigger GLP-1 Release predominantly by accessing basolaterally located G protein-coupled bile acid receptors. Endocrinology 156: 3961–3970.
137. Lorenzo-Zuniga, V. et al. 2003. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology 37: 551–557.
138. Inagaki, T. et al. 2006. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl. Acad. Sci. U.S.A. 103: 3920–3925.
139. Pournaras, D.J. et al. 2012. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 153: 3613–3619.
140. Patti, M.E. et al. 2009. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 17: 1671–1677
141. Bhutta, H.Y. et al. 2015. Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats. PLoS One 10: e0122273.
142. Nakatani, H. et al. 2009. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism 58: 1400–1407.
143. Kohli, R. et al. 2013. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J. Clin. Endocrinol. Metab. 98: E708–E712.
144. Steinert, R.E. et al. 2013. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring) 21: E660–E668.
145. Midtvedt, T., A. Norman & K. Nygaard. 1969. Bile acid transforming micro-organisms in rats with an intestinal blind segment. Acta Pathol. Microbiol. Scand. 77: 162–166.
146. Holt, J.A. et al. 2003. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17: 1581–1591.
147. Fang, S. et al. 2015. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat. Med. 21: 159–165.
148. Ryan, K.K. et al. 2014. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509: 183–188.
149. Flynn, C.R. et al. 2015. Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Nat. Commun. 6: 7715.